Clinical efficacy of HER3 partners' inhibitors in ERBB3 mutated cancer patients
Verlingue, L., Massard, C., Hollebecque, A., Alvarez, E. Castanon, Postel-Vinay, S., Angevin, E., Armand, J-P., Aspeslagh, S., Varga, A., Ratislav, B., Gazzah, A., Michot, J-M., Lacroix, L., De Baere,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw363.70
Date:
October, 2016
File:
PDF, 37 KB
english, 2016